William Blair downgraded Clarivate from Outperform to Mkt Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/6/2024 | Outperform → Mkt Perform | William Blair | |
| 12/15/2023 | $8.00 | Equal Weight → Underweight | Wells Fargo |
| 10/16/2023 | $10.00 → $8.50 | Hold → Buy | Jefferies |
| 9/8/2023 | $8.00 → $7.00 | Equal Weight → Underweight | Barclays |
| 8/25/2023 | $9.00 → $8.00 | Outperform → Sector Perform | RBC Capital Mkts |
| 8/7/2023 | $10.00 → $6.00 | Neutral → Underperform | BofA Securities |
| 8/4/2023 | $15.00 → $8.00 | Overweight → Equal Weight | Wells Fargo |
| 6/13/2023 | $11.00 | Outperform | Oppenheimer |
William Blair downgraded Clarivate from Outperform to Mkt Perform
Wells Fargo downgraded Clarivate from Equal Weight to Underweight and set a new price target of $8.00
Jefferies upgraded Clarivate from Hold to Buy and set a new price target of $8.50 from $10.00 previously
LONDON, Nov. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2024. Third Quarter 2024 Financial Highlights Revenues of $622.2 million decreased 3.9%Organic revenues decreased 2.6%, as an increase in subscription revenues of 0.6% was offset by a decrease in re-occurring revenues of 1.1% and transactional and other revenues of 13.6%Net loss of $65.6 million; Net loss per diluted share of $0.09Adjusted net income(1) of $134.1
LONDON, Oct. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the third quarter 2024 before the market opens on Wednesday, November 6, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Wednesday, November 6, 2024 to review the results. The webcast is open to all in
Chief Executive Jonathan Gear to Step Down as CEO and Member of the Board LONDON, Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced that the Board has appointed Matti Shem Tov, former CEO of ProQuest, as the Company's next CEO, effective August 9, 2024. Mr. Shem Tov will also join the Company's Board of Directors. Jonathan Gear, Chief Executive Officer, will step down as CEO and as a member of the Board at that time, and will transition into a non-executive role until November 1, 2024. "The Board
Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series. This multipart special report offers an in-depth analysis of the therapeutic trends, regulatory actions and economic shifts that defined biopharma, med tech and scientific innovation over the past year while forecasting key developments for 2025. As the biopharma and med-tech indu
New modular analytics solution empowers commercial teams to optimize strategies and improve patient outcomes LONDON, Jan. 14, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Fusion, an innovative platform to support commercial analytics in life sciences. Powered by integrated real-world data and built by clinical and data science experts, Fusion provides biopharma and medtech organizations with the tools to understand and act in varied disease and competitive landscapes — eliminating the complexities of raw data management.
LONDON, Dec. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that its Board of Directors (the "Board") authorized a new share repurchase program of up to $500 million of the Company's outstanding ordinary shares through open-market purchases for a period of two years, from January 1, 2025 through December 31, 2026. The new share repurchase program replaces the current share repurchase program which terminates December 31, 2024, under which the Company repurchased $300 m
8-K - CLARIVATE PLC (0001764046) (Filer)
8-K/A - CLARIVATE PLC (0001764046) (Filer)
10-Q - CLARIVATE PLC (0001764046) (Filer)
SC 13G/A - CLARIVATE PLC (0001764046) (Subject)
SC 13G - CLARIVATE PLC (0001764046) (Subject)
SC 13D/A - CLARIVATE PLC (0001764046) (Subject)
4 - CLARIVATE PLC (0001764046) (Issuer)
4 - CLARIVATE PLC (0001764046) (Issuer)
4 - CLARIVATE PLC (0001764046) (Issuer)
4 - CLARIVATE PLC (0001764046) (Issuer)
4 - CLARIVATE PLC (0001764046) (Issuer)
Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,
Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader
Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.